Responses
Neurogastroenterology
A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 20 March 2006
- Published on: 20 March 2006Unmet needs for IBS therapiesShow More
Dear Editor,
We have read with great interest the recent manuscript published in GUT by Professor Tack and colleagues entitled “A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation (IBS-C)”.[Tack et al. 2005] To date, this is the largest clinical trial assessing the efficacy and safety of repeated tegaserod therapy...
Conflict of Interest:
None declared.